BERTRAM GUDRUN
No ORCID on file
· 14 papers in corpus
· active 1998
Frequent coauthors
- KURISCHKO ANATOLI 14
- KASCH HELMUT 14
- MENZENBACH BERND 14
- PONSOLD KURT 14
- ROHRIG HEIDEMARIE 14
- SCHUBERT GERD 14
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …